MAY 28, 2018 03:13 PM PDT

Bacterial Toxin Linked to Inflammatory Bowel Disease

WRITTEN BY: Carmen Leitch

The gut is home to a community of microbes, the microbiome, which plays a major role in human health and disease. While some of those bacteria and microorganisms are beneficial, others can pose problems. New research has indicated that a common toxin made by the common intestinal bacterium Escherichia coli, microcin B17, is connected to inflammatory bowel disease (IBD), a collection of illnesses that includes ulcerative colitis and Crohn’s disease. An international group of researchers from the John Innes Centre in Norwich, UK, and Brigham and Women's Hospital in Boston, USA have reported these findings in Cell.

E. coli bacteria / Image credit: Pixnio

The work was the result of a serendipitous observation made while scientists were trying to develop new antibiotics. It will open up new treatment avenues for IBD patients. E. coli typically makes microcin B17 toxin to battle and dominate other bacteria. 

“This is largely a chance finding. We have been studying this toxin for its antibacterial properties, and we were contacted by Professor Richard Blumberg who leads the Boston group for quite different reasons - they thought there might be a connection between the toxin and IBD,” explained Professor Tony Maxwell.

The investigators collaborated to show that as the toxin breaks down, the byproducts that are created can cause inflammation in the gut, which is a big factor in IBD. In addition, the study found that one type of aromatic organic compounds, the oxazole class, is a trigger of gastrointestinal inflammation that is caused by microbes and the environment. 

“These findings will advance our understanding of how gut inflammation associated with IBD may be triggered and offer new hope of potential future therapy,” said Dr. Fred Collin, a postdoctoral fellow who was a key part of the research in Professor Maxwell's lab.

Genetic tools like genome-wide association studies, which identify links between changes in genes and physiological conditions, have helped elucidate some of the genetic causes of IBD. Environmental contributions and patient reactions have not been clearly defined yet. 

"The bacteria that live inside us have a lot of impact on well-being and the twist here is that it's not the E. coli bacteria but the toxin that's produced by the bacteria that appears to have an effect," explained Maxwell. "They produce these toxins to kill their neighbors in their fight for ecological niches but it appears that the breakdown products of the toxin can initiate gut inflammation," he added.

This work adds to the growing body of evidence illustrating the connection between the microbes in our gastrointestinal system and our health. Learn more about the gut microbiome from the video.

 

Sources: AAAS/Eurekalert! Via John Innes Centre, Cell

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 16, 2018
Immunology
APR 16, 2018
Epstein-Barr Virus Raises Risk of 7 Diseases in Addition to Mono
The repercussions of an infection with Epstein-Barr virus (EBV) may not end with mononucleosis, “mono” or “the kissing disease.” Fi...
APR 26, 2018
Cardiology
APR 26, 2018
New Gene Linked to Human Aortic Aneurysms
Using a web tool called GeneMatcher, scientists from Baylor College of Medicine studying defective copies of the ari-1 gene were matched up with scientists...
APR 30, 2018
Clinical & Molecular DX
APR 30, 2018
Reducing Dependency on Antibiotics in Hospitals
How can small community and rural hospitals create antibiotic stewardship programs to reduce the danger of antibiotic resistance? Scientists from the Inter...
JUN 16, 2018
Clinical & Molecular DX
JUN 16, 2018
Nanoparticles Deliver "Theranostics" for Cancer Patients
New technology combing therapeutic agents and diagnostics (theranostics) can be used to deliver drugs to cancer cells. From the Moscow Institute of Physics...
AUG 08, 2018
Microbiology
AUG 08, 2018
Use of Probiotics Linked to Severe Bloating, Brain Fog
Gut bacteria can have a powerful effect on brain function....
AUG 22, 2018
Clinical & Molecular DX
AUG 22, 2018
New Clinical Assay Useful For Urothelial Cancer
U.S. Food and Drug Administration (FDA) has now approved a pharmDx assay called ‘Dako PD-L1 IHC 22C3’ by Agilent Technologies Inc. for use in u...
Loading Comments...